Sign in

CIK 0001665988

  • Accelerated filer
  • Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
810980861
Phone
+1 919-474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
  1. 4 Open-market sale Director sold 12,000 shares at $8.79 ($105,439)
  2. 4 Shares withheld for taxes SVP & CFO gave up 9,429 shares (to pay taxes)
  3. 4 Shares withheld for taxes SVP & Chief Compliance Officer gave up 2,133 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP & General Counsel gave up 6,327 shares (to pay taxes)
  5. 4 Shares withheld for taxes President and CEO gave up 41,717 shares (to pay taxes)
  6. 4 Open-market sale Director sold 10,000 shares at $7.57 ($75,658)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 17,701 shares at $7.42 ($131,255)
  9. 4 Option exercise Director acquired 7,575 shares (option exercise)
  10. 4 Option exercise Director acquired 26,493 shares (option exercise)
  11. 4 Option exercise Director acquired 26,493 shares (option exercise)
  12. 4 Option exercise Director acquired 26,493 shares (option exercise)
  13. 4 Option exercise Director acquired 26,493 shares (option exercise)
  14. 4 Option exercise Director acquired 26,493 shares (option exercise)
  15. 4 Option exercise Director acquired 26,493 shares (option exercise)
  16. 4 Option exercise Director acquired 26,493 shares (option exercise)
  17. 4 Option exercise Director acquired 26,493 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 4 Option exercise Director acquired 26,493 shares (option exercise)
  20. 4 Planned sale SVP & CFO sold 3,875 shares at $7.57 ($29,334)

Page 2 of 13 · 251 filings